Drugs (Pharmaceuticals)
-
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Ever since Medicare proposed to sharply limit coverage of the controversial Alzheimer’s drug Aduhelm, the agency has been deluged with…
Read More » -
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
In the interview, Mr. Johns echoed these explanations. Asked if association officials had communicated with Biogen since Medicare’s proposal, he…
Read More » -
House Passes Bill to Limit Cost of Insulin to $35 a Month
The pharmaceutical industry opposed the drug price regulations in the social spending and climate legislation, but it has not vocally…
Read More » -
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Older
WASHINGTON — Federal regulators authorized second booster shots of the Pfizer-BioNTech and Moderna coronavirus vaccines on Tuesday for everyone 50…
Read More »
